• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Rafael Holdings Inc (NY: RFL )

    1.380 -0.050 (-3.50%)
    Official Closing Price Updated: 7:00 PM EDT, Jul 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 106,375
    Open 1.400
    Bid (Size) 1.340 (21)
    Ask (Size) 1.550 (1)
    Prev. Close 1.430
    Today's Range 1.300 - 1.450
    52wk Range 1.290 - 2.520
    Shares Outstanding 100
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    RFL Stock Earnings: Rafael Holdings Reported Results for Q3 2024
    Rafael Holdings just reported results for the third quarter of 2024. 
    Via InvestorPlace
    Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
    Strategically focused on generating shareholder value by advancing our portfolio and identifying attractive investment opportunities with substantive upside potential 
    From Rafael Holdings, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -24.59%
    -24.59%
    1 Month
    -6.76%
    -6.76%
    3 Month
    -23.33%
    -23.33%
    6 Month
    -22.25%
    -22.25%
    1 Year
    -32.68%
    -32.68%

    More News

    Read More
    Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    RFL Stock Earnings: Rafael Holdings Reported Results for Q1 2024
    Via InvestorPlace
    Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Rafael Holdings Announces up to $5 Million Share Repurchase Program
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Top Real Estate Stocks That May Plunge
    Via Benzinga
    Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer
    From Cornerstone Pharmaceuticals
    Via GlobeNewswire
    Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
    Via Benzinga
    Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.